Next Article in Journal
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe
Next Article in Special Issue
Tat-hspb1 Suppresses Clear Cell Renal Cell Carcinoma (ccRCC) Growth via Lysosomal Membrane Permeabilization
Previous Article in Journal
Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer
Previous Article in Special Issue
Emerging Targets in Clear Cell Renal Cell Carcinoma
 
 
Review

Article Versions Notes

Cancers 2022, 14(21), 5313; https://doi.org/10.3390/cancers14215313
Action Date Notes Link
article pdf uploaded. 28 October 2022 16:13 CEST Version of Record https://www.mdpi.com/2072-6694/14/21/5313/pdf-vor
article xml file uploaded 8 November 2022 04:50 CET Original file -
article xml uploaded. 8 November 2022 04:50 CET Update -
article pdf uploaded. 8 November 2022 04:50 CET Updated version of record https://www.mdpi.com/2072-6694/14/21/5313/pdf-vor
article html file updated 8 November 2022 04:51 CET Original file -
article xml file uploaded 8 November 2022 04:55 CET Update -
article xml uploaded. 8 November 2022 04:55 CET Update https://www.mdpi.com/2072-6694/14/21/5313/xml
article pdf uploaded. 8 November 2022 04:55 CET Updated version of record https://www.mdpi.com/2072-6694/14/21/5313/pdf
article html file updated 8 November 2022 04:56 CET Update -
article html file updated 28 February 2023 20:28 CET Update -
article html file updated 2 March 2023 01:21 CET Update https://www.mdpi.com/2072-6694/14/21/5313/html
Back to TopTop